(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-3-(4-benzylphenyl)-2-[[(2S)-3-(1H-indol-3-yl)-2-[[2-(2-thienyl)acetyl]amino]propanoyl]amino]propanoyl]amino]-5-guanidino-pentanoyl]pyrrolidine-2-carbonyl]amino]-5-guanidino-pentanoyl]amino]butanediamide

ID: ALA4752011

Chembl Id: CHEMBL4752011

PubChem CID: 162653188

Max Phase: Preclinical

Molecular Formula: C54H69N15O8S

Molecular Weight: 1088.31

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(Cc2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)Cc1cccs1)C(=O)N[C@@H](CC(N)=O)C(N)=O

Standard InChI:  InChI=1S/C54H69N15O8S/c55-45(70)30-41(47(56)72)67-48(73)39(15-6-22-61-53(57)58)65-51(76)44-17-8-24-69(44)52(77)40(16-7-23-62-54(59)60)66-49(74)42(27-34-20-18-33(19-21-34)26-32-10-2-1-3-11-32)68-50(75)43(64-46(71)29-36-12-9-25-78-36)28-35-31-63-38-14-5-4-13-37(35)38/h1-5,9-14,18-21,25,31,39-44,63H,6-8,15-17,22-24,26-30H2,(H2,55,70)(H2,56,72)(H,64,71)(H,65,76)(H,66,74)(H,67,73)(H,68,75)(H4,57,58,61)(H4,59,60,62)/t39-,40-,41-,42-,43-,44-/m0/s1

Standard InChI Key:  UOJWPVVTQHYCRD-WGXSSYHUSA-N

Alternative Forms

  1. Parent:

    ALA4752011

    ---

Associated Targets(Human)

NMUR1 Tchem Neuromedin-U receptor 1 (374 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1088.31Molecular Weight (Monoisotopic): 1087.5174AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Takayama K,Mori K,Asari T,Sohma Y,Nomura E,Sasaki Y,Taguchi A,Taniguchi A,Miyazato M,Minamino N,Kangawa K,Hayashi Y.  (2020)  Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability.,  30  (18): [PMID:32721452] [10.1016/j.bmcl.2020.127436]

Source